US Pharma MarketingTarsus joins Stargardt race to market with $800m Alkeus takeover
Alongside Alkeus, companies like Belite Bio, Ocugen and Nanoscope are aiming to secure a place on the Stargardt market with no approved drugs.
Alongside Alkeus, companies like Belite Bio, Ocugen and Nanoscope are aiming to secure a place on the Stargardt market with no approved drugs.
Source: Pharmaceutical Technology